An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare.

NCT ID: NCT06212479

Last Updated: 2025-04-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-05-17

Study Completion Date

2037-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, single-arm, observational study capturing data from whole-body magnetic resonance imagining (WB-MRI) from up to 100,000 male and female subjects 18 years of age or older recruited at multiple clinical sites within the United States. Study subjects must meet a set of inclusion and exclusion criteria. Potential subjects arriving at the study sites will be evaluated for enrollment. It is the Principal Investigator's (PI) responsibility to enroll only subjects who satisfy the inclusion/exclusion criteria. Recruitment can occur by subject presentation at the sites for elective standard screening, word-of-mouth, flyers, healthcare professional (HCP) referrals, advertisement online, or any other means, subject to approval by the associated institutional review board (IRB) or ethics committee (EC) when applicable.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Metabolic Disease Aneurysm Neurologic Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MRI Scan Arm

Whole Body MRI Scan

MRI Scan

Intervention Type DIAGNOSTIC_TEST

Whole Body MRI Scan

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MRI Scan

Whole Body MRI Scan

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Each subject MUST:

* Be\>=18 years of age at the time of enrollment.
* Be able to read and understand provided procedural information for the study;
* Be able and willing to follow all study procedures including proper breathing and body movement minimization while within the WB-MRI system;
* Be willing and able to provide required clinical, demographic, medical history, and concomitant medications information;
* Be able to provide financial payment in advance for reimbursement of the cost of the WBMRI acquisition procedure and interpretation;
* Complete all required consent procedures.

Exclusion Criteria

* Harbor within their bodies contraindicated medical devices including, but not limited to, implanted pacemakers, intracranial aneurysm clips, cochlear implants, drug infusion pumps, neurostimulators, bone growth stimulators, certain intrauterine contraceptive devices, non- MRI safe metals, etc.;

* Self-certify that they are pregnant;
* Be seeking to undergo WB-MRI as a subject in this study in lieu of other covered dedicated diagnostic imaging evaluations when such covered procedures represent more appropriate or standard-of-care procedures by context-specific clinical indication;
* Be an employee of the study site or the sponsor;
* Have a medical condition or serious intercurrent illness, or other circumstance that, in the Investigator's judgment, could jeopardize the candidate's safety as a study subject, or that could interfere with study objectives.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Prenuvo Inc

UNKNOWN

Sponsor Role collaborator

Hercules

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Perry Kaneriya, MD, MBA

Role: PRINCIPAL_INVESTIGATOR

Hercules

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hercules Research Center

Watertown, Massachusetts, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kayla MacLeod, BS

Role: CONTACT

(301) 450-4451

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sarah Hemeon, BS

Role: primary

617-203-7565

Gerimar Leon, BS

Role: backup

(617) 362-3570

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MA- 001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MRI in Renal Tumors
NCT02325921 COMPLETED
Testing New Method of Analyzing MR Images
NCT00630318 TERMINATED PHASE1